Hematology/Oncology Testing

Hematopoietic malignancies derive the greatest benefit from expert review and the application of advanced technologies. It is here that Genzyme’s analysis “expands the boundaries” from pure diagnosis to prognostic and therapeutic analysis. Our experts interpret all the diverse data on these types of tumors and formulate an integrated, accurate diagnosis which encompasses any molecular or cytogenetic features that may affect the prognosis and therapy of the disease.

Our comprehensive approach to lymphoma and leukemia analysis gives physicians one source for integrated information and medical consultation.

Take a Look at Our Numbers

20%	We see 20% of all newly diagnosed cases of suspected leukemia and lymphoma in the U.S.
305,000	We have completed over 305,000 flow cytometry analyses for leukemia and lymphoma.
36,715	We have completed over 36,715 bone morphology studies.
47	We offer 47 hematology/oncology specific FISH probes.
13	We have 13 full-time hematopathologists on staff who have extensive experience in difficult-to-diagnose cases.
25	We have over 25 years of experience diagnosing hematologic malignancies.

For your convenience, we have posted a PDF of our informative physician brochure on this page.

		Search by Test Name or Condition:
		Search by Test Name:
		Select a test .... ABL Kinase Domain Mutation Analysis in CML Alliance RQ-PCR Analysis AML1/ETO by PCR – t(8;21) by RT-PCR B-Cell Gene Rearrangements by PCR BCR-ABL - t(9;22) by RT-PCR (Quantitative) Bone Marrow - Peripheral Blood Smear Interpretation Bone Marrow - Smear Interpretation Bone Marrow Morphology - Complete Studies Bone Marrow Morphology - Cytochemistry Breast Cancer - DNA Ploidy/S-Phase Analysis by Flow Cytometry Breast Cancer - Individual Markers by IHC Breast Cancer - Interactive Quantitative Cellular Analysis (i QCA) Breast Cancer - Profiles Chromosome Analysis - Blood Chromosome Analysis - Bone Marrow Chromosome Analysis - Solid Tumor CLL-MRD (Minimial Residual Disease) by Flow Cytometry Colorectal Cancer - DNA Ploidy/S-Phase Analysis by Flow Cytometry Colorectal Cancer - Individual Markers by IHC Colorectal Cancer - Microsatellite Instability by PCR Colorectal Cancer - Profiles DNA Ploidy Analysis by Image Analysis DNA Ploidy/S-Phase Analysis by Flow Cytometry Drug Resistance Assay (DRA™) EGFR Amplification by FISH in NSCLC EGFR Mutation Analysis in NSCLC FIP1L1-PDGFRa Analysis in Hypereosinophilic Syndrome (HES) Disorders FISH (Fluorescence In Situ Hybridization) Flow Cytometry - interactiveFLOW Flow Cytometry, Six-Color (Immunophenotyping) Hematopathology Consultation Services HER2 by FISH (PathVysion) IgVH Mutation Analysis in B-CLL Immunohistochemistry (IHC) Immunohistochemistry (IHC) - Complex Tumor Analysis Immunohistochemistry (IHC) - Individual Markers Infectious Agents by Immunohistochemistry Infectious Agents by In Situ Hybridation Inv(16) RT-PCR JAK2 Mutation Analysis in Myeloproliferative Disorders KRAS Mutation Analysis Micrometastases - Bone Marrow/Peripheral Blood/Stem Cell Micrometastases - Melanoma/Carcinoma in Lymph Node Molar Pregnancy Evaluation (p57 and DNA Ploidy/S-Phase) Morphology – Special Stains p53 Mutation Analysis in B-CLL Pathology Consultation Services Peripheral Blood Smear Interpretation PML/RARA – t(15;17) by RT-PCR T-Cell Gene Rearrangements by PCR UGT1A1 Molecular Assay Urovysion™ by FISH